What is Altratech?
Established in 2013 and headquartered in Clare, Ireland, Altratech designs advanced biosensor and semiconductor chip technology. Their core focus is on enabling DNA testing for food traceability, a critical component for ensuring safety and transparency within the agriculture industry. By providing precise and reliable testing solutions, Altratech aims to enhance food safety standards and build consumer trust through verifiable supply chain data. The company's technological advancements position it as a key player in the agritech and food safety markets.
How much funding has Altratech raised?
Altratech has raised a total of $29.7M across 8 funding rounds:
Angel/Seed
$1.2M
Private Equity
$1.5M
Grant
$3.4M
Unspecified
$2.5M
Multiple Rounds
$9.6M
Other Financing Round
$11.5M
Angel/Seed (2014): $1.2M with participation from Enterprise Ireland and Kernel Capital
Private Equity (2016): $1.5M led by Kernel Capital
Grant (2017): $3.4M, investors not publicly disclosed
Unspecified (2017): $2.5M featuring Kernel Capital Growth Fund
Other Financing Round (2021): $4.1M, investors not publicly disclosed
Unspecified (2021): $3.9M with participation from The Bank of Ireland Kernel Capital Growth Fund and Infinity Capital
Debt (2021): $1.6M led by Claret Capital
Other Financing Round (2024): $11.5M supported by European Innovation Council and SMEs Executive Agency (EISMEA
Key Investors in Altratech
European Innovation Council and SMEs Executive Agency (EISMEA
The European Innovation Council and SMEs Executive Agency (EISMEA) manages European innovation initiatives and SME programs, aiming to foster technological advancement and business growth across the continent.
Kernel Capital
Kernel Capital is a venture capital and private equity firm focused on investing in growth-stage and early-stage companies, providing both capital and strategic guidance to drive scaling and successful exits.
Enterprise Ireland
Enterprise Ireland is a government agency dedicated to the development and growth of Irish businesses in manufacturing and internationally traded services, supporting innovation and global competitiveness.
What's next for Altratech?
The substantial enterprise-level funding, including the recent strategic investment, signals a pivotal growth phase for Altratech. This capital injection is expected to accelerate product development, expand market reach, and bolster manufacturing capabilities. Altratech is likely to leverage this financing to scale its operations, forge new partnerships within the agricultural and food industries, and further enhance its biosensor technology. The company's trajectory suggests a strong focus on solidifying its position as a leader in DNA-based food traceability solutions, potentially driving significant advancements in global food safety and supply chain management.
See full Altratech company page
